Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Nov 13, 2014 van plew daniel p Officer Sell 8,575 399.21 - 399.95
Aug 15, 2011 goldberg murray a Officer Automatic Sell 8,591 56.61
Jan 5, 2010 vagelos p roy Director Disposition (Non Open Market) 8,595 n/a
Jan 3, 2008 vagelos p roy Director Automatic Sell 8,658 n/a
May 7, 2013 terifay robert j Officer Disposition (Non Open Market) 8,692 261.67
Aug 18, 2014 aberman michael s Officer Option Execute 8,750 52.03
Jan 3, 2011 vagelos p roy Director Automatic Sell 8,957 34.04
Oct 20, 2010 gilman alfred g Director Disposition (Non Open Market) 9,000 n/a
Jan 11, 2012 terifay robert j Officer Automatic Sell 9,019 74.20
Jul 2, 2010 vagelos p roy Director Disposition (Non Open Market) 9,021 n/a
Feb 15, 2012 mccorkle douglas s Officer Sell 9,097 111.08
Dec 18, 2013 powchik peter Officer Automatic Sell 9,162 264.86 - 270.20
Oct 2, 2013 schleifer leonard s Officer Automatic Sell 9,162 312.44 - 317.34
Oct 6, 2008 vagelos p roy Director Disposition (Non Open Market) 9,270 n/a
Dec 16, 2013 stahl neil Officer Automatic Sell 9,302 272.73
Aug 11, 2014 vagelos p roy Officer Sell 9,372 340.02 - 341.02
Dec 12, 2013 yancopoulos george Officer Automatic Sell 9,382 273.06
Mar 9, 2011 mccorkle douglas s Officer Automatic Sell 9,400 40.00
Mar 9, 2011 mccorkle douglas s Officer Option Execute 9,400 20.32
Feb 1, 2012 terifay robert j Officer Automatic Sell 9,439 90.54 - 91.04
Showing 401-420 of 897 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)